 | • レポートコード：QFJ1-4067 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、CRISPRベース治療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ゲノム編集、遺伝子工学、gRNAデータベース/遺伝子ライブラリー、CRISPRプラスミド、ヒト幹細胞、遺伝子組み換え生物/作物、細胞株工学）、用途別市場規模（バイオテクノロジー企業、製薬企業、学術機関、研究開発機関）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・CRISPRベース治療法の市場動向 ・企業の競争状況、市場シェア ・CRISPRベース治療法の種類別市場規模と予測2016-2027（ゲノム編集、遺伝子工学、gRNAデータベース/遺伝子ライブラリー、CRISPRプラスミド、ヒト幹細胞、遺伝子組み換え生物/作物、細胞株工学） ・CRISPRベース治療法の用途別市場規模と予測2016-2027（バイオテクノロジー企業、製薬企業、学術機関、研究開発機関） ・CRISPRベース治療法の北米市場規模2016-2027（アメリカ、カナダ） ・CRISPRベース治療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・CRISPRベース治療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・CRISPRベース治療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・CRISPRベース治療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Caribou Biosciences、Addgene、CRISPR THERAPEUTICS、Merck KGaA、Mirus Bio LLC、Editas Medicine、Takara Bio USA、Thermo Fisher Scientific、Horizon Discovery Group、Intellia Therapeutics、GE Healthcare Dharmacon） ・結論 |
CRISPR‐based genome editing technology has become an important potential therapeutic tool for various diseases.
Market Analysis and Insights: Global CRISPR-Based Therapeutics Market
The global CRISPR-Based Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CRISPR-Based Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CRISPR-Based Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CRISPR-Based Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CRISPR-Based Therapeutics market.
Global CRISPR-Based Therapeutics Scope and Market Size
CRISPR-Based Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CRISPR-Based Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Genome Editing
Genetic Engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Caribou Biosciences
Addgene
CRISPR THERAPEUTICS
Merck KGaA
Mirus Bio LLC
Editas Medicine
Takara Bio USA
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
GE Healthcare Dharmacon
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRISPR-Based Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Genome Editing
1.2.3 Genetic Engineering
1.2.4 gRNA Database/Gene Librar
1.2.5 CRISPR Plasmid
1.2.6 Human Stem Cells
1.2.7 Genetically Modified Organisms/Crops
1.2.8 Cell Line Engineering
1.3 Market by Application
1.3.1 Global CRISPR-Based Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Academic Institutes
1.3.5 Research and Development Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global CRISPR-Based Therapeutics Market Perspective (2016-2027)
2.2 CRISPR-Based Therapeutics Growth Trends by Regions
2.2.1 CRISPR-Based Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 CRISPR-Based Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 CRISPR-Based Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 CRISPR-Based Therapeutics Industry Dynamic
2.3.1 CRISPR-Based Therapeutics Market Trends
2.3.2 CRISPR-Based Therapeutics Market Drivers
2.3.3 CRISPR-Based Therapeutics Market Challenges
2.3.4 CRISPR-Based Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRISPR-Based Therapeutics Players by Revenue
3.1.1 Global Top CRISPR-Based Therapeutics Players by Revenue (2016-2021)
3.1.2 Global CRISPR-Based Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global CRISPR-Based Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CRISPR-Based Therapeutics Revenue
3.4 Global CRISPR-Based Therapeutics Market Concentration Ratio
3.4.1 Global CRISPR-Based Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRISPR-Based Therapeutics Revenue in 2020
3.5 CRISPR-Based Therapeutics Key Players Head office and Area Served
3.6 Key Players CRISPR-Based Therapeutics Product Solution and Service
3.7 Date of Enter into CRISPR-Based Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRISPR-Based Therapeutics Breakdown Data by Type
4.1 Global CRISPR-Based Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global CRISPR-Based Therapeutics Forecasted Market Size by Type (2022-2027)
5 CRISPR-Based Therapeutics Breakdown Data by Application
5.1 Global CRISPR-Based Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global CRISPR-Based Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America CRISPR-Based Therapeutics Market Size (2016-2027)
6.2 North America CRISPR-Based Therapeutics Market Size by Type
6.2.1 North America CRISPR-Based Therapeutics Market Size by Type (2016-2021)
6.2.2 North America CRISPR-Based Therapeutics Market Size by Type (2022-2027)
6.2.3 North America CRISPR-Based Therapeutics Market Size by Type (2016-2027)
6.3 North America CRISPR-Based Therapeutics Market Size by Application
6.3.1 North America CRISPR-Based Therapeutics Market Size by Application (2016-2021)
6.3.2 North America CRISPR-Based Therapeutics Market Size by Application (2022-2027)
6.3.3 North America CRISPR-Based Therapeutics Market Size by Application (2016-2027)
6.4 North America CRISPR-Based Therapeutics Market Size by Country
6.4.1 North America CRISPR-Based Therapeutics Market Size by Country (2016-2021)
6.4.2 North America CRISPR-Based Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe CRISPR-Based Therapeutics Market Size (2016-2027)
7.2 Europe CRISPR-Based Therapeutics Market Size by Type
7.2.1 Europe CRISPR-Based Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe CRISPR-Based Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe CRISPR-Based Therapeutics Market Size by Type (2016-2027)
7.3 Europe CRISPR-Based Therapeutics Market Size by Application
7.3.1 Europe CRISPR-Based Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe CRISPR-Based Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe CRISPR-Based Therapeutics Market Size by Application (2016-2027)
7.4 Europe CRISPR-Based Therapeutics Market Size by Country
7.4.1 Europe CRISPR-Based Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe CRISPR-Based Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific CRISPR-Based Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific CRISPR-Based Therapeutics Market Size by Type
8.2.1 Asia-Pacific CRISPR-Based Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific CRISPR-Based Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific CRISPR-Based Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific CRISPR-Based Therapeutics Market Size by Application
8.3.1 Asia-Pacific CRISPR-Based Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific CRISPR-Based Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific CRISPR-Based Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific CRISPR-Based Therapeutics Market Size by Region
8.4.1 Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America CRISPR-Based Therapeutics Market Size (2016-2027)
9.2 Latin America CRISPR-Based Therapeutics Market Size by Type
9.2.1 Latin America CRISPR-Based Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America CRISPR-Based Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America CRISPR-Based Therapeutics Market Size by Type (2016-2027)
9.3 Latin America CRISPR-Based Therapeutics Market Size by Application
9.3.1 Latin America CRISPR-Based Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America CRISPR-Based Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America CRISPR-Based Therapeutics Market Size by Application (2016-2027)
9.4 Latin America CRISPR-Based Therapeutics Market Size by Country
9.4.1 Latin America CRISPR-Based Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America CRISPR-Based Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRISPR-Based Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa CRISPR-Based Therapeutics Market Size by Type
10.2.1 Middle East & Africa CRISPR-Based Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa CRISPR-Based Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa CRISPR-Based Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa CRISPR-Based Therapeutics Market Size by Application
10.3.1 Middle East & Africa CRISPR-Based Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa CRISPR-Based Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa CRISPR-Based Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa CRISPR-Based Therapeutics Market Size by Country
10.4.1 Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Caribou Biosciences
11.1.1 Caribou Biosciences Company Details
11.1.2 Caribou Biosciences Business Overview
11.1.3 Caribou Biosciences CRISPR-Based Therapeutics Introduction
11.1.4 Caribou Biosciences Revenue in CRISPR-Based Therapeutics Business (2016-2021)
11.1.5 Caribou Biosciences Recent Development
11.2 Addgene
11.2.1 Addgene Company Details
11.2.2 Addgene Business Overview
11.2.3 Addgene CRISPR-Based Therapeutics Introduction
11.2.4 Addgene Revenue in CRISPR-Based Therapeutics Business (2016-2021)
11.2.5 Addgene Recent Development
11.3 CRISPR THERAPEUTICS
11.3.1 CRISPR THERAPEUTICS Company Details
11.3.2 CRISPR THERAPEUTICS Business Overview
11.3.3 CRISPR THERAPEUTICS CRISPR-Based Therapeutics Introduction
11.3.4 CRISPR THERAPEUTICS Revenue in CRISPR-Based Therapeutics Business (2016-2021)
11.3.5 CRISPR THERAPEUTICS Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Details
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA CRISPR-Based Therapeutics Introduction
11.4.4 Merck KGaA Revenue in CRISPR-Based Therapeutics Business (2016-2021)
11.4.5 Merck KGaA Recent Development
11.5 Mirus Bio LLC
11.5.1 Mirus Bio LLC Company Details
11.5.2 Mirus Bio LLC Business Overview
11.5.3 Mirus Bio LLC CRISPR-Based Therapeutics Introduction
11.5.4 Mirus Bio LLC Revenue in CRISPR-Based Therapeutics Business (2016-2021)
11.5.5 Mirus Bio LLC Recent Development
11.6 Editas Medicine
11.6.1 Editas Medicine Company Details
11.6.2 Editas Medicine Business Overview
11.6.3 Editas Medicine CRISPR-Based Therapeutics Introduction
11.6.4 Editas Medicine Revenue in CRISPR-Based Therapeutics Business (2016-2021)
11.6.5 Editas Medicine Recent Development
11.7 Takara Bio USA
11.7.1 Takara Bio USA Company Details
11.7.2 Takara Bio USA Business Overview
11.7.3 Takara Bio USA CRISPR-Based Therapeutics Introduction
11.7.4 Takara Bio USA Revenue in CRISPR-Based Therapeutics Business (2016-2021)
11.7.5 Takara Bio USA Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific CRISPR-Based Therapeutics Introduction
11.8.4 Thermo Fisher Scientific Revenue in CRISPR-Based Therapeutics Business (2016-2021)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Horizon Discovery Group
11.9.1 Horizon Discovery Group Company Details
11.9.2 Horizon Discovery Group Business Overview
11.9.3 Horizon Discovery Group CRISPR-Based Therapeutics Introduction
11.9.4 Horizon Discovery Group Revenue in CRISPR-Based Therapeutics Business (2016-2021)
11.9.5 Horizon Discovery Group Recent Development
11.10 Intellia Therapeutics
11.10.1 Intellia Therapeutics Company Details
11.10.2 Intellia Therapeutics Business Overview
11.10.3 Intellia Therapeutics CRISPR-Based Therapeutics Introduction
11.10.4 Intellia Therapeutics Revenue in CRISPR-Based Therapeutics Business (2016-2021)
11.10.5 Intellia Therapeutics Recent Development
11.11 GE Healthcare Dharmacon
11.11.1 GE Healthcare Dharmacon Company Details
11.11.2 GE Healthcare Dharmacon Business Overview
11.11.3 GE Healthcare Dharmacon CRISPR-Based Therapeutics Introduction
11.11.4 GE Healthcare Dharmacon Revenue in CRISPR-Based Therapeutics Business (2016-2021)
11.11.5 GE Healthcare Dharmacon Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global CRISPR-Based Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Genome Editing
Table 3. Key Players of Genetic Engineering
Table 4. Key Players of gRNA Database/Gene Librar
Table 5. Key Players of CRISPR Plasmid
Table 6. Key Players of Human Stem Cells
Table 7. Key Players of Genetically Modified Organisms/Crops
Table 8. Key Players of Cell Line Engineering
Table 9. Global CRISPR-Based Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global CRISPR-Based Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global CRISPR-Based Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global CRISPR-Based Therapeutics Market Share by Regions (2016-2021)
Table 13. Global CRISPR-Based Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global CRISPR-Based Therapeutics Market Share by Regions (2022-2027)
Table 15. CRISPR-Based Therapeutics Market Trends
Table 16. CRISPR-Based Therapeutics Market Drivers
Table 17. CRISPR-Based Therapeutics Market Challenges
Table 18. CRISPR-Based Therapeutics Market Restraints
Table 19. Global CRISPR-Based Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global CRISPR-Based Therapeutics Market Share by Players (2016-2021)
Table 21. Global Top CRISPR-Based Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR-Based Therapeutics as of 2020)
Table 22. Ranking of Global Top CRISPR-Based Therapeutics Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by CRISPR-Based Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players CRISPR-Based Therapeutics Product Solution and Service
Table 26. Date of Enter into CRISPR-Based Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global CRISPR-Based Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 29. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2016-2021)
Table 30. Global CRISPR-Based Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global CRISPR-Based Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global CRISPR-Based Therapeutics Revenue Market Share by Application (2016-2021)
Table 34. Global CRISPR-Based Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global CRISPR-Based Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America CRISPR-Based Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 37. North America CRISPR-Based Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America CRISPR-Based Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 39. North America CRISPR-Based Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America CRISPR-Based Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America CRISPR-Based Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe CRISPR-Based Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe CRISPR-Based Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe CRISPR-Based Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe CRISPR-Based Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe CRISPR-Based Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe CRISPR-Based Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific CRISPR-Based Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific CRISPR-Based Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific CRISPR-Based Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific CRISPR-Based Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific CRISPR-Based Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America CRISPR-Based Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America CRISPR-Based Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America CRISPR-Based Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America CRISPR-Based Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America CRISPR-Based Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America CRISPR-Based Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa CRISPR-Based Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa CRISPR-Based Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa CRISPR-Based Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa CRISPR-Based Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa CRISPR-Based Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 66. Caribou Biosciences Company Details
Table 67. Caribou Biosciences Business Overview
Table 68. Caribou Biosciences CRISPR-Based Therapeutics Product
Table 69. Caribou Biosciences Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Caribou Biosciences Recent Development
Table 71. Addgene Company Details
Table 72. Addgene Business Overview
Table 73. Addgene CRISPR-Based Therapeutics Product
Table 74. Addgene Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Addgene Recent Development
Table 76. CRISPR THERAPEUTICS Company Details
Table 77. CRISPR THERAPEUTICS Business Overview
Table 78. CRISPR THERAPEUTICS CRISPR-Based Therapeutics Product
Table 79. CRISPR THERAPEUTICS Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
Table 80. CRISPR THERAPEUTICS Recent Development
Table 81. Merck KGaA Company Details
Table 82. Merck KGaA Business Overview
Table 83. Merck KGaA CRISPR-Based Therapeutics Product
Table 84. Merck KGaA Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Merck KGaA Recent Development
Table 86. Mirus Bio LLC Company Details
Table 87. Mirus Bio LLC Business Overview
Table 88. Mirus Bio LLC CRISPR-Based Therapeutics Product
Table 89. Mirus Bio LLC Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Mirus Bio LLC Recent Development
Table 91. Editas Medicine Company Details
Table 92. Editas Medicine Business Overview
Table 93. Editas Medicine CRISPR-Based Therapeutics Product
Table 94. Editas Medicine Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Editas Medicine Recent Development
Table 96. Takara Bio USA Company Details
Table 97. Takara Bio USA Business Overview
Table 98. Takara Bio USA CRISPR-Based Therapeutics Product
Table 99. Takara Bio USA Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Takara Bio USA Recent Development
Table 101. Thermo Fisher Scientific Company Details
Table 102. Thermo Fisher Scientific Business Overview
Table 103. Thermo Fisher Scientific Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Thermo Fisher Scientific Recent Development
Table 105. Horizon Discovery Group Company Details
Table 106. Horizon Discovery Group Business Overview
Table 107. Horizon Discovery Group CRISPR-Based Therapeutics Product
Table 108. Horizon Discovery Group Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Horizon Discovery Group Recent Development
Table 110. Intellia Therapeutics Company Details
Table 111. Intellia Therapeutics Business Overview
Table 112. Intellia Therapeutics CRISPR-Based Therapeutics Product
Table 113. Intellia Therapeutics Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
Table 114. Intellia Therapeutics Recent Development
Table 115. GE Healthcare Dharmacon Company Details
Table 116. GE Healthcare Dharmacon Business Overview
Table 117. GE Healthcare Dharmacon CRISPR-Based Therapeutics Product
Table 118. GE Healthcare Dharmacon Revenue in CRISPR-Based Therapeutics Business (2016-2021) & (US$ Million)
Table 119. GE Healthcare Dharmacon Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CRISPR-Based Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Genome Editing Features
Figure 3. Genetic Engineering Features
Figure 4. gRNA Database/Gene Librar Features
Figure 5. CRISPR Plasmid Features
Figure 6. Human Stem Cells Features
Figure 7. Genetically Modified Organisms/Crops Features
Figure 8. Cell Line Engineering Features
Figure 9. Global CRISPR-Based Therapeutics Market Share by Application: 2020 VS 2027
Figure 10. Biotechnology Companies Case Studies
Figure 11. Pharmaceutical Companies Case Studies
Figure 12. Academic Institutes Case Studies
Figure 13. Research and Development Institutes Case Studies
Figure 14. CRISPR-Based Therapeutics Report Years Considered
Figure 15. Global CRISPR-Based Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global CRISPR-Based Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global CRISPR-Based Therapeutics Market Share by Regions: 2020 VS 2027
Figure 18. Global CRISPR-Based Therapeutics Market Share by Regions (2022-2027)
Figure 19. Global CRISPR-Based Therapeutics Market Share by Players in 2020
Figure 20. Global Top CRISPR-Based Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR-Based Therapeutics as of 2020
Figure 21. The Top 10 and 5 Players Market Share by CRISPR-Based Therapeutics Revenue in 2020
Figure 22. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2016-2021)
Figure 23. Global CRISPR-Based Therapeutics Revenue Market Share by Type (2022-2027)
Figure 24. North America CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America CRISPR-Based Therapeutics Market Share by Type (2016-2027)
Figure 26. North America CRISPR-Based Therapeutics Market Share by Application (2016-2027)
Figure 27. North America CRISPR-Based Therapeutics Market Share by Country (2016-2027)
Figure 28. United States CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe CRISPR-Based Therapeutics Market Share by Type (2016-2027)
Figure 32. Europe CRISPR-Based Therapeutics Market Share by Application (2016-2027)
Figure 33. Europe CRISPR-Based Therapeutics Market Share by Country (2016-2027)
Figure 34. Germany CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific CRISPR-Based Therapeutics Market Share by Type (2016-2027)
Figure 42. Asia-Pacific CRISPR-Based Therapeutics Market Share by Application (2016-2027)
Figure 43. Asia-Pacific CRISPR-Based Therapeutics Market Share by Region (2016-2027)
Figure 44. China CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America CRISPR-Based Therapeutics Market Share by Type (2016-2027)
Figure 52. Latin America CRISPR-Based Therapeutics Market Share by Application (2016-2027)
Figure 53. Latin America CRISPR-Based Therapeutics Market Share by Country (2016-2027)
Figure 54. Mexico CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa CRISPR-Based Therapeutics Market Share by Type (2016-2027)
Figure 58. Middle East & Africa CRISPR-Based Therapeutics Market Share by Application (2016-2027)
Figure 59. Middle East & Africa CRISPR-Based Therapeutics Market Share by Country (2016-2027)
Figure 60. Turkey CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE CRISPR-Based Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Caribou Biosciences Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
Figure 64. Addgene Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
Figure 65. CRISPR THERAPEUTICS Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
Figure 66. Merck KGaA Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
Figure 67. Mirus Bio LLC Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
Figure 68. Editas Medicine Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
Figure 69. Takara Bio USA Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
Figure 70. Thermo Fisher Scientific Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
Figure 71. Horizon Discovery Group Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
Figure 72. Intellia Therapeutics Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
Figure 73. GE Healthcare Dharmacon Revenue Growth Rate in CRISPR-Based Therapeutics Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
CRISPR＆CRISPR関連（Cas）遺伝子のグローバル市場2021 Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid. The CRISPR/Cas system is a pro…- 世界のCRISPRゲノム編集市場規模・現状・予測（2021年-2027年） CRISPR Genome editing is a group of technologies that give scientists the ability to change CRISPR. Market Analysis and Insights: Global CRISPR Genome Editing Market The global CRISPR Genome Editing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of X…
- 世界の遺伝子編集ツール市場規模・現状・予測（2021年-2027年） Gene editing (or genome editing) is the insertion, deletion or replacement of DNA at a specific site in the genome of an organism or cell. It is usually achieved in the lab using engineered nucleases also known as molecular scissors. Market Analysis and Insights: Global Gene Editing Tools Market The…
- 世界のCRISPR＆Cas遺伝子市場規模・現状・予測（2021年-2027年） CRISPR (clustered regularly interspaced short palindromic repeats) is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of bacteriophages that had previously infected the prokaryote. They are used to d…
- 世界の遺伝子編集技術市場規模・現状・予測（2021年-2027年） Gene editing is a new and accurate genetic engineering technology that can modify specific target genes in the genome of an organism. Gene editing technology refers to the ability for humans to "edit" targeted genes to achieve modifications to specific DNA fragments. Gene editing relies on genetical…